According to a recent LinkedIn post from Pear VC, the venture firm is highlighting portfolio company Greatly Health’s $4M seed round backed by Pear, Commonweal Ventures, and Flare Capital Partners. The post describes Greatly Health as building a new category of cancer care that integrates exercise, nutrition, and mind‑body interventions into the treatment journey.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post points to clinical validation at Memorial Sloan Kettering, citing a 16% improvement in two‑year overall survival, a 69% reduction in hospitalizations, and 42% fewer treatment disruptions. A quoted comment from Pear partner Eddie Eltoukhy argues that Greatly’s model has already delivered meaningful improvements and is now being scaled via technology and industry partnerships.
For investors, the post suggests Pear VC is increasing exposure to tech‑enabled oncology care models with evidence‑based outcomes. If Greatly Health can successfully commercialize and scale its validated approach, Pear VC could benefit from value creation at the intersection of digital health, oncology, and cost‑reduction in care delivery.
More broadly, the content underscores ongoing venture interest in healthcare platforms that promise both clinical efficacy and lower acute care utilization. This may position Pear VC competitively in the healthtech segment, potentially enhancing the firm’s portfolio diversification and long‑term return prospects if such models gain payer and provider adoption.